Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

SHA:603439 Revenue

Guizhou Sanli Pharmaceutical Co.,Ltd had revenue of 408.59M CNY in the quarter ending March 31, 2025, a decrease of -3.18%. This brings the company's revenue in the last twelve months to 2.13B, up 24.76% year-over-year. In the year 2024, Guizhou Sanli Pharmaceutical Co.,Ltd had annual revenue of 2.14B with 31.16% growth.

• Revenue (ttm): 2.13B
• Revenue Growth: +24.76%
• P/S Ratio: 2.22
• Revenue / Employee: 933.81K
• Employees: 2,282
• Market Cap: 4.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.14B	509.41M	31.16%
Dec 31, 2023	1.63B	433.66M	36.10%
Dec 31, 2022	1.20B	262.35M	27.94%
Dec 31, 2021	938.97M	308.74M	48.99%
Dec 31, 2020	630.22M	-253.56M	-28.69%